Skip to main content
. Author manuscript; available in PMC: 2010 Sep 30.
Published in final edited form as: Am J Geriatr Pharmacother. 2009 Jun;7(3):167–185. doi: 10.1016/j.amjopharm.2009.06.003

Table III.

Completed phase 2 trials.

Agent Date of Trial
Completion
Mechanism of Action
FAILED
  AN179271,72 2003 Active Aβ immunization
  SGA-74278 2005 GABAB receptor antagonist
  Lecozotan SR74 2008 Selective 5-HT1A receptor antagonist
SUCCESSFUL
 Huperzine A79,80 2007 ChEI
 Intravenous immunoglobulin (IVIg)84 2008 Passive immunization
 Methylthioninium chloride (TRx0014)86,87 2008 Dissolves and inhibits formation of
neurofibrillary tangles